Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	31.73	36.11	27.41
Graham Fair Price	-23.85	3.29	4.31
PEG	875.41	-0.56	0.06
Price/Book	33.28	1.30	0.98
Price/Cash Flow	22.10	-105.99	-136.05
Prices/Earnings	18.30	11.93	10.08
Price/Sales	26.38	2.14	1.69
Price/FCF	22.10	-105.99	-136.05
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-17.77	0.21	0.26
Operating Margin	-3.39	0.06	0.06
ROA	12.82	0.01	< 0.005
ROE	0.02	0.03	12.66
ROIC	0.02	0.02	11.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.23	-98.24
Dividends QOQ	-0.40	5.97	1381.71
EBIT QOQ	1.74	0.02	-98.65
EPS QOQ	1.77	-0.21	-87.87
FCF QOQ	-1.25	-0.72	42.57
Revenue QOQ	0.07	0.06	-9.92
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	61.52	54.83	-10.88
Days Sales Outstanding (DSO)	95.98	96.84	0.90
Inventory Turnover	1.46	1.64	12.21
Debt/Capitalization	0.30	0.30	-0.03
Quick Ratio	0.58	0.69	17.46
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	5.84	4.25	-27.22
Cash	0.37	0.06	-83.09
Capex	-0.09	0.09	5.72
Free Cash Flow	-0.04	-0.05	-22.75
Revenue	3.38	2.55	-24.34
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.94	0.94	-0.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.83	6.90	18.31
Naive Interpretation	Member

06 - Financial Health · Bad

Rating